Dynavax Historical Income Statement

DVAX Stock  USD 12.41  0.04  0.32%   
Historical analysis of Dynavax Technologies income statement accounts such as Other Operating Expenses of 270.9 M or Ebit of 14.4 M can show how well Dynavax Technologies performed in making a profits. Evaluating Dynavax Technologies income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Dynavax Technologies's future profits or losses.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Dynavax Technologies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Dynavax Technologies is a good buy for the upcoming year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.

About Dynavax Income Statement Analysis

Dynavax Technologies Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Dynavax Technologies shareholders. The income statement also shows Dynavax investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Dynavax Technologies Income Statement Chart

Dynavax Technologies Income Statement is one of the three primary financial statements used for reporting Dynavax's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Dynavax Technologies revenue and expense. Dynavax Technologies Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Dynavax Technologies' Net Income From Continuing Ops is fairly stable compared to the past year. Non Operating Income Net Other is likely to rise to about 9.3 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 4.1 M in 2024.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Dynavax Technologies. It is also known as Dynavax Technologies overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Total Revenue

Total revenue comprises all receipts Dynavax Technologies generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.
Most accounts from Dynavax Technologies' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Dynavax Technologies current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.At this time, Dynavax Technologies' Net Income From Continuing Ops is fairly stable compared to the past year. Non Operating Income Net Other is likely to rise to about 9.3 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 4.1 M in 2024.
 2023 2024 (projected)
Interest Income26.8M28.1M
Non Recurring15.4M16.1M

Dynavax Technologies income statement Correlations

0.650.740.410.40.010.430.620.4-0.020.620.580.410.4-0.10.370.640.42-0.010.790.25-0.210.870.54
0.650.360.090.08-0.280.110.340.010.290.240.21-0.020.03-0.440.220.480.03-0.20.750.08-0.560.780.76
0.740.360.750.79-0.060.810.810.77-0.240.940.940.730.76-0.220.430.850.83-0.150.760.520.20.690.19
0.410.090.750.99-0.460.990.240.980.030.930.910.830.98-0.14-0.070.460.93-0.270.30.120.040.26-0.2
0.40.080.790.99-0.471.00.350.990.020.950.950.790.99-0.13-0.010.560.97-0.220.370.280.170.3-0.21
0.01-0.28-0.06-0.46-0.47-0.460.26-0.41-0.73-0.28-0.280.0-0.430.180.55-0.17-0.370.2-0.15-0.030.15-0.160.06
0.430.110.810.991.0-0.460.370.990.020.960.960.80.99-0.130.00.590.97-0.210.40.290.170.34-0.18
0.620.340.810.240.350.260.370.33-0.360.580.620.330.32-0.110.690.910.480.120.820.80.430.720.33
0.40.010.770.980.99-0.410.990.330.00.940.940.811.00.01-0.010.520.98-0.110.30.260.210.25-0.26
-0.020.29-0.240.030.02-0.730.02-0.360.0-0.11-0.11-0.320.040.17-0.64-0.04-0.030.140.09-0.06-0.250.130.0
0.620.240.940.930.95-0.280.960.580.94-0.110.990.830.93-0.190.20.710.94-0.220.570.370.140.510.0
0.580.210.940.910.95-0.280.960.620.94-0.110.990.80.93-0.150.230.750.96-0.160.580.450.230.51-0.03
0.41-0.020.730.830.790.00.80.330.81-0.320.830.80.8-0.130.150.340.75-0.30.190.010.010.16-0.21
0.40.030.760.980.99-0.430.990.321.00.040.930.930.80.01-0.020.520.98-0.110.310.250.190.26-0.26
-0.1-0.44-0.22-0.14-0.130.18-0.13-0.110.010.17-0.19-0.15-0.130.01-0.08-0.190.020.88-0.330.10.38-0.3-0.37
0.370.220.43-0.07-0.010.550.00.69-0.01-0.640.20.230.15-0.02-0.080.460.110.030.390.370.180.330.16
0.640.480.850.460.56-0.170.590.910.52-0.040.710.750.340.52-0.190.460.660.030.90.830.370.810.31
0.420.030.830.930.97-0.370.970.480.98-0.030.940.960.750.980.020.110.66-0.050.410.450.360.34-0.24
-0.01-0.2-0.15-0.27-0.220.2-0.210.12-0.110.14-0.22-0.16-0.3-0.110.880.030.03-0.05-0.060.350.42-0.060.0
0.790.750.760.30.37-0.150.40.820.30.090.570.580.190.31-0.330.390.90.41-0.060.620.030.960.61
0.250.080.520.120.28-0.030.290.80.26-0.060.370.450.010.250.10.370.830.450.350.620.770.520.11
-0.21-0.560.20.040.170.150.170.430.21-0.250.140.230.010.190.380.180.370.360.420.030.77-0.07-0.4
0.870.780.690.260.3-0.160.340.720.250.130.510.510.160.26-0.30.330.810.34-0.060.960.52-0.070.67
0.540.760.19-0.2-0.210.06-0.180.33-0.260.00.0-0.03-0.21-0.26-0.370.160.31-0.240.00.610.11-0.40.67
Click cells to compare fundamentals

Dynavax Technologies Account Relationship Matchups

Dynavax Technologies income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization6.7M8.1M7.8M14.7M7.3M4.1M
Interest Expense17.0M19.1M11.2M6.7M6.8M4.0M
Other Operating Expenses156.7M121.8M306.0M440.2M258.0M270.9M
Operating Income(121.5M)(75.2M)134.5M283.5M(37.0M)(38.9M)
Ebit(121.5M)(75.2M)134.5M283.5M13.7M14.4M
Research Development62.3M28.6M32.2M46.6M54.9M51.9M
Ebitda(114.8M)(67.2M)142.3M298.2M21.0M22.0M
Total Operating Expenses137.3M107.9M132.4M178.0M207.8M218.2M
Net Income(151.4M)(91.8M)76.7M293.2M(6.4M)(6.7M)
Income Tax Expense(1.2M)16.5M808K1.1M2.0M2.1M
Total Revenue35.2M46.6M439.4M722.7M232.3M243.9M
Gross Profit15.8M32.6M265.9M460.5M182.1M191.2M
Cost Of Revenue19.4M13.9M173.6M262.2M50.2M52.1M
Income Before Tax(152.6M)(75.2M)77.5M294.3M(4.4M)(4.6M)
Total Other Income Expense Net(31.1M)(18K)(57.0M)10.8M(3.9M)(4.1M)
Selling General Administrative75.0M79.3M100.2M131.4M152.9M160.6M
Net Income From Continuing Ops(155.2M)(82.9M)76.7M293.2M61.1M64.2M
Non Operating Income Net Other(3.4M)4.5M(53.5M)9.8M8.8M9.3M
Net Income Applicable To Common Shares(155.9M)(75.2M)81.3M292.9M336.8M353.6M
Interest Income3.4M1.3M140K7.9M26.8M28.1M
Net Interest Income(13.6M)(17.8M)(11.0M)1.2M20.0M21.0M
Reconciled Depreciation21.5M9.3M7.0M6.7M6.8M8.0M

Dynavax Technologies Investors Sentiment

The influence of Dynavax Technologies' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Dynavax. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Dynavax Technologies' public news can be used to forecast risks associated with an investment in Dynavax. The trend in average sentiment can be used to explain how an investor holding Dynavax can time the market purely based on public headlines and social activities around Dynavax Technologies. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Dynavax Technologies' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Dynavax Technologies' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Dynavax Technologies' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Dynavax Technologies.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Dynavax Technologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Dynavax Technologies' short interest history, or implied volatility extrapolated from Dynavax Technologies options trading.

Pair Trading with Dynavax Technologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dynavax Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynavax Technologies will appreciate offsetting losses from the drop in the long position's value.

Moving together with Dynavax Stock

  0.66MBRX Moleculin Biotech Financial Report 9th of May 2024 PairCorr
  0.83MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against Dynavax Stock

  0.8EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.77MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
  0.63MDWD Mediwound Downward RallyPairCorr
  0.53CLVRW Clever Leaves HoldingsPairCorr
The ability to find closely correlated positions to Dynavax Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dynavax Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dynavax Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dynavax Technologies to buy it.
The correlation of Dynavax Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dynavax Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dynavax Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dynavax Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Dynavax Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dynavax Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dynavax Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dynavax Technologies Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.
Note that the Dynavax Technologies information on this page should be used as a complementary analysis to other Dynavax Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Complementary Tools for Dynavax Stock analysis

When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Is Dynavax Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dynavax Technologies. If investors know Dynavax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dynavax Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Earnings Share
(0.05)
Revenue Per Share
1.804
Quarterly Revenue Growth
(0.70)
Return On Assets
(0.02)
The market value of Dynavax Technologies is measured differently than its book value, which is the value of Dynavax that is recorded on the company's balance sheet. Investors also form their own opinion of Dynavax Technologies' value that differs from its market value or its book value, called intrinsic value, which is Dynavax Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dynavax Technologies' market value can be influenced by many factors that don't directly affect Dynavax Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dynavax Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dynavax Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dynavax Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.